HUP0100375A2 - Baccatin-és oxazolszármazékok és alkalmazásuk paclitaxel és analógjai szintézisében - Google Patents

Baccatin-és oxazolszármazékok és alkalmazásuk paclitaxel és analógjai szintézisében

Info

Publication number
HUP0100375A2
HUP0100375A2 HU0100375A HUP0100375A HUP0100375A2 HU P0100375 A2 HUP0100375 A2 HU P0100375A2 HU 0100375 A HU0100375 A HU 0100375A HU P0100375 A HUP0100375 A HU P0100375A HU P0100375 A2 HUP0100375 A2 HU P0100375A2
Authority
HU
Hungary
Prior art keywords
baccatin
paclitaxel
analogs
intermediates
synthesis
Prior art date
Application number
HU0100375A
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of HUP0100375A2 publication Critical patent/HUP0100375A2/hu
Publication of HUP0100375A3 publication Critical patent/HUP0100375A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU0100375A 1997-11-21 1998-11-19 Baccatin and oxazol derivatives and their use as intermediates in the synthesis of paclitaxel and analogs HUP0100375A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/975,804 US5917062A (en) 1997-11-21 1997-11-21 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
PCT/IB1998/001912 WO1999026939A1 (en) 1997-11-21 1998-11-19 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs

Publications (2)

Publication Number Publication Date
HUP0100375A2 true HUP0100375A2 (hu) 2001-12-28
HUP0100375A3 HUP0100375A3 (en) 2002-04-29

Family

ID=25523419

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100375A HUP0100375A3 (en) 1997-11-21 1998-11-19 Baccatin and oxazol derivatives and their use as intermediates in the synthesis of paclitaxel and analogs

Country Status (20)

Country Link
US (2) US5917062A (hu)
EP (1) EP1049686B9 (hu)
JP (1) JP3445973B2 (hu)
KR (1) KR100545436B1 (hu)
CN (1) CN1229364C (hu)
AT (1) ATE308533T1 (hu)
AU (1) AU746448C (hu)
CA (1) CA2310778C (hu)
CZ (1) CZ296350B6 (hu)
DE (1) DE69832202T2 (hu)
DK (1) DK1049686T3 (hu)
ES (1) ES2251106T3 (hu)
HK (1) HK1028046A1 (hu)
HU (1) HUP0100375A3 (hu)
NO (1) NO20002600L (hu)
PL (1) PL192422B1 (hu)
RU (1) RU2213739C2 (hu)
SI (1) SI1049686T1 (hu)
SK (1) SK285797B6 (hu)
WO (1) WO1999026939A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19925926A1 (de) * 1999-06-08 2000-12-14 Bayer Ag Katalysatoren auf Basis Titan-haltiger, organisch-anorganischer Hybridmaterialien zur selektiven Oxidation von Kohlenwasserstoffen
JP4502338B2 (ja) * 1999-09-17 2010-07-14 株式会社横浜国際バイオ研究所 タキソイド化合物の製造法
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
IT1319682B1 (it) 2000-12-06 2003-10-23 Indena Spa Procedimento di sintesi del paclitaxel.
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20020782A1 (it) * 2002-04-12 2003-10-13 Indena Spa Processo semisintetico per la preparazione di n-debenzoilpaclitaxel
NZ576355A (en) * 2006-10-20 2012-04-27 Scinopharm Singapore Pte Ltd Process for making crystalline anhydrous docetaxel
EP2358693A4 (en) * 2008-11-20 2012-04-18 Reddys Lab Ltd Dr PREPARATION OF DOCETAXEL
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34277A (en) * 1862-01-28 Improvement in lamps
FR2601676B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
USRE34277E (en) * 1988-04-06 1993-06-08 Centre National De La Recherche Scientifique Process for preparing taxol
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
MY110249A (en) * 1989-05-31 1998-03-31 Univ Florida State Method for preparation of taxol using beta lactam
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
CA2071160A1 (en) * 1991-07-31 1993-02-01 Vittorio Farina Asymmetric synthesis of taxol side chain
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5470866A (en) * 1992-08-18 1995-11-28 Virginia Polytechnic Institute And State University Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
US5703247A (en) * 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
CA2170661A1 (en) * 1995-03-22 1996-09-23 John K. Thottathil Novel methods for the preparation of taxanes using oaxzolidine intermediates
IT1275435B (it) * 1995-05-19 1997-08-07 Indena Spa Derivati della 10-desacetil-14beta-idrossibaccatina iii,loro metodo di preparazione e formulazioni che li contengono
KR100225535B1 (ko) * 1996-08-27 1999-10-15 정지석 파클리탁셀의 제조방법

Also Published As

Publication number Publication date
PL192422B1 (pl) 2006-10-31
AU746448C (en) 2002-12-05
CZ296350B6 (cs) 2006-02-15
AU1170599A (en) 1999-06-15
ES2251106T3 (es) 2006-04-16
DK1049686T3 (da) 2006-01-16
NO20002600L (no) 2000-07-17
EP1049686A1 (en) 2000-11-08
CZ20001869A3 (cs) 2000-11-15
NO20002600D0 (no) 2000-05-19
WO1999026939A1 (en) 1999-06-03
AU746448B2 (en) 2002-05-02
KR20010024619A (ko) 2001-03-26
DE69832202T2 (de) 2006-07-13
PL340553A1 (en) 2001-02-12
SI1049686T1 (sl) 2006-02-28
DE69832202D1 (de) 2005-12-08
HUP0100375A3 (en) 2002-04-29
JP2001524476A (ja) 2001-12-04
US5907042A (en) 1999-05-25
CA2310778C (en) 2005-02-22
US5917062A (en) 1999-06-29
CA2310778A1 (en) 1999-06-03
CN1279677A (zh) 2001-01-10
CN1229364C (zh) 2005-11-30
JP3445973B2 (ja) 2003-09-16
KR100545436B1 (ko) 2006-01-24
HK1028046A1 (en) 2001-02-02
EP1049686B1 (en) 2005-11-02
ATE308533T1 (de) 2005-11-15
RU2213739C2 (ru) 2003-10-10
SK285797B6 (sk) 2007-08-02
SK7322000A3 (en) 2000-11-07
EP1049686B9 (en) 2005-12-28

Similar Documents

Publication Publication Date Title
NO20002443D0 (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
SG97813A1 (en) Synthesis of taxol and its derivatives
IL214165A0 (en) Intermediates useful in the synthesis of statin derivatives
MA26855A1 (fr) Activateurs de glucokinases transolefiniques
ID23975A (id) Bahan bergelombang heterogen untuk artikel-artikel bahan penyerab
NO20001275D0 (no) Strukturerte abrasiver med pÕfestede funksjonelle pulvere
ZA200000036B (en) Isolation and purification of taxanes and taxane analogues.
IL149592A0 (en) Synthesis of 2'-deoxy-l-nucleosides
HUP0100375A3 (en) Baccatin and oxazol derivatives and their use as intermediates in the synthesis of paclitaxel and analogs
FI972346A0 (fi) Foerfarande och anordning foer foerverkligande av oeverfoeringsfoerbindelse
ID24700A (id) Partikel hidroksiapatit berpori sebagai pembawa bahan obat
IL141238A0 (en) New use of taxoid derivatives
IL117486A (en) Processes for the preparation of taxanes utilizing oxazolidine derivatives
BR9710648A (pt) S¡ntese de indolilmaleimidas
IL133672A (en) Formulations of paclitaxel free of cremophor
HUP0201266A3 (en) Semi-synthesis of paclitaxel using dialkyldichlorosilanes
GB9405400D0 (en) Taxane derivatives
EE9900568A (et) Pentaerütriidi uued derivaadid, nende valmistamine, kasutamine ja vaheühendid nende sünteesiks
GB2296239B (en) Taxane derivatives
HUP0104000A3 (en) New use of taxoid derivatives
HU9602904D0 (en) Pharmaceutical compositions containing taxanes of anti-cancer activity
TW402906U (en) Improvement of Planet Jupiter plaque structure
FI972454A0 (fi) Foerfarande och anordning foer framstaellning av en tyristorkylinraettning
FI970895A0 (fi) Foerfarande och anordning foer faestande av en borrbult
TW379541U (en) Structure improvement of belt tip